Screening

Type 1 diabetes can begin developing long before symptoms appear. Autoantibody screening can identify people at increased risk early, creating opportunities for monitoring, education, and access to treatments that may delay disease progression. STEPS is expanding access to free screening across Florida through community events, at-home test kits, and local labs.

Current Screening Sites


Screening Sites Map

Goals

GOAL 01

To screen 100k people per year in the state of Florida.

diabetic-person-checking-their-glucose-level-

Goal 02

Ensure screening for T1D becomes part of the standard of care in pediatrics.

Pediatrician examining a baby with a stethoscope while a parent holds the child.

Goal 03

To fundamentally understand T1D and discover new treatment options that will preserve beta cell function.

Elderly female scientist in a lab coat and gloves writes on a clipboard at a clean, bright lab station, with a blue liquid in a flask nearby.


Are you at higher risk?

Higher risk criteria include individuals who have a first or second degree relative with type 1 diabetes. Additionally, individuals with existing diagnosis of single organ auto immune conditions such as: Hashimoto’s, Graves, Celica disease, vitiligo, Ulcerative colitis, Crohn’s disease, myasthenia gravis and multiple sclerosis are considered to be at higher risk and should be screened for autoantibodies of type 1 diabetes. 


Types of Screening

Buccal swab

Buccal Swab Icon

Finger Stick test

Screening Icon

Blood work for confirmation

Swab Icon

If you have tested previously and would like to be connected to an Health Care Provider for confirmation and follow up care, please contact us below. 

MD-PEDS-endocrinology

Dr. Michael J Haller

Phone: (352) 273-9264
Email: hallerms@ufl.edu

pic

MD-PEDS-endocrinology

Arash Taghvai, M.D.

Phone: (352) 273-9264
Email: arash.taghvai@ufl.edu

MD-PEDS-endocrinology

Jennifer L Hosford

Phone: (352) 294-5759
Email: jennifer.hosford@peds.ufl.edu